Muscle-derived nitric oxide synthase expression, differences associated with muscle fiber-type, and disease susceptibility in a rat model of myasthenia gravis
- 31 December 2006
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 121 (3), 286-293
- https://doi.org/10.1016/j.clim.2006.07.005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disordersNeuromuscular Disorders, 2005
- Short-circuiting autoimmune disease by target-tissue-derived nitric oxideClinical Immunology, 2004
- Clinical evaluation and management of myasthenia gravisMuscle & Nerve, 2004
- Role for Interferon-γ in Rat Strains with Different Susceptibility to Experimental Autoimmune Myasthenia GravisClinical Immunology, 2000
- Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis ratsClinical and Experimental Immunology, 1999
- Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophagesEuropean Journal of Immunology, 1998
- Interferon γ (IFN-γ) Is Necessary for the Genesis of Acetylcholine Receptor–induced Clinical Experimental Autoimmune Myasthenia gravis in MiceThe Journal of Experimental Medicine, 1997
- Myasthenia GravisNew England Journal of Medicine, 1994
- Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: Subsetting of serum antibodies by preparative isoelectric focusingClinical Immunology and Immunopathology, 1992
- Repetitive nerve stimulation vs. twitch tension in rats with EAMGMuscle & Nerve, 1992